Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Charleston Labs and Daiichi Sankyo Receive CRL from FDA for NDA for CL-108 Tablets for Oral Use

americanpharmaceuticalreviewFebruary 08, 2017

Tag: Charleston Labs , NDA for CL-108 Tablets for Oral Use

PharmaSources Customer Service